Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate

MLA

Ioana S. Barac, et al. “Interleukins (IL-23 and IL-27) Serum Levels: Relationships with Gene Polymorphisms and Disease Patterns in Multiple Sclerosis Patients under Treatment with Interferon and Glatiramer Acetate.” Heliyon, vol. 9, no. 6, June 2023. EBSCOhost, https://doi.org/10.1016/j.heliyon.2023.e17427.

APA

Ioana S. Barac, Vitalie Văcăraș, Mihaela Iancu, Dafin F. Mureșanu, & Lucia M. Procopciuc. (2023). Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate. Heliyon, 9(6). https://doi.org/10.1016/j.heliyon.2023.e17427

Chicago

Ioana S. Barac, Vitalie Văcăraș, Mihaela Iancu, Dafin F. Mureșanu, and Lucia M. Procopciuc. 2023. “Interleukins (IL-23 and IL-27) Serum Levels: Relationships with Gene Polymorphisms and Disease Patterns in Multiple Sclerosis Patients under Treatment with Interferon and Glatiramer Acetate.” Heliyon 9 (6). doi:10.1016/j.heliyon.2023.e17427.